2014 UALC
Monte Winslow, PhD
Stanford University
Research Project:
Novel metastasis-specific vulnerabilities: therapeutic targets for advanced lung adenocarcinoma
Summary:
Several factors contribute to the poor outcome of lung cancer patients but our lack of drugs that specifically kill metastases is a major impediment to successful therapy. Recent revolutionary advances in genomic technologies have allowed Dr. Winslow’s group to reduce the expression of each gene in the genome individually and then determine which genes are required for metastatic cancer cell viability. Dr. Winslow’s study may uncover critical new vulnerabilities that could be exploited to eradicate metastases and significantly improve lung cancer patient outcomes.